Clearmind Medicine (CMND) - 2022 Q4 - Annual Report
Clearmind Medicine (CMND)2023-02-05 16:00
Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☒ Emerging Growth Company ☒ If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐ †The term "new or revised financial accounting standard" refers to any update issued by ...